Evidence map›Paper›PMID 28289232›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Transcriptional landscape of the human cell cycle.

Yin Liu, Sujun Chen, Su Wang, Fraser Soares, Martin Fischer, Feilong Meng, Zhou Du, Charles Lin, Clifford Meyer, James A DeCaprio and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 167 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Yin LiuClinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China.
Sujun ChenClinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China.
Su WangDepartment of Bioinformatics, School of Life Sciences, Tongji University, Shanghai 200092, China.
Fraser SoaresPrincess Margaret Cancer Center, University Health Network, Toronto, ON M5G1L7, Canada.
Martin FischerDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215.
Feilong MengState Key Laboratory of Molecular Biology, Chinese Academy of Sciences Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.
Zhou DuDepartment of Bioinformatics, School of Life Sciences, Tongji University, Shanghai 200092, China.
Charles LinDepartment of Molecular and Human Genetics; Baylor College of Medicine Houston, TX 77030.
Clifford MeyerCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.
James A DeCaprioDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215.
Myles BrownCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; myles_brown@dfci.harvard.edu xsliu@jimmy.harvard.edu hansenhe@uhnresearch.ca.
X Shirley LiuCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; myles_brown@dfci.harvard.edu xsliu@jimmy.harvard.edu hansenhe@uhnresearch.ca.
Housheng Hansen HePrincess Margaret Cancer Center, University Health Network, Toronto, ON M5G1L7, Canada; myles_brown@dfci.harvard.edu xsliu@jimmy.harvard.edu hansenhe@uhnresearch.ca.ORCID 0000-0003-2898-3363
Tongji University · CNHarvard University · USDana-Farber Cancer Institute · USUniversity Health Network · CABaylor College of Medicine · USChinese Academy of Sciences · CN

Funding

RB-RELATED PROTEINS IN SV4OT AND E1A TRANSFORMATIONR01CA063113 · NCI · DANA-FARBER CANCER INSTITUTE · PI DECAPRIO, JAMES A. · 1994 to 2018
$5.0M
Transforming Mechanisms of Merkel Cell Polyoma VirusR01CA173023 · NCI · DANA-FARBER CANCER INST · PI DECAPRIO, JAMES A. · 2013 to 2019
$2.3M
Inferring Mammalian Transcriptional Regulatory Networks from EpigenomicsR01GM099409 · NIGMS · DANA-FARBER CANCER INST · PI LIU, XIAOLE SHIRLEY · 2011 to 2014
$1.4M
CIHRHoward Hughes Medical InstituteNCI NIH HHS R01 CA063113NCI NIH HHS R01 CA173023NIGMS NIH HHS R01 GM099409
6 · The paper itself

Abstract

Steady-state gene expression across the cell cycle has been studied extensively. However, transcriptional gene regulation and the dynamics of histone modification at different cell-cycle stages are largely unknown. By applying a combination of global nuclear run-on sequencing (GRO-seq), RNA sequencing (RNA-seq), and histone-modification Chip sequencing (ChIP-seq), we depicted a comprehensive transcriptional landscape at the G0/G1, G1/S, and M phases of breast cancer MCF-7 cells. Importantly, GRO-seq and RNA-seq analysis identified different cell-cycle-regulated genes, suggesting a lag between transcription and steady-state expression during the cell cycle. Interestingly, we identified genes actively transcribed at early M phase that are longer in length and have low expression and are accompanied by a global increase in active histone 3 lysine 4 methylation (H3K4me2) and histone 3 lysine 27 acetylation (H3K27ac) modifications. In addition, we identified 2,440 cell-cycle-regulated enhancer RNAs (eRNAs) that are strongly associated with differential active transcription but not with stable expression levels across the cell cycle. Motif analysis of dynamic eRNAs predicted Kruppel-like factor 4 (KLF4) as a key regulator of G1/S transition, and this identification was validated experimentally. Taken together, our combined analysis characterized the transcriptional and histone-modification profile of the human cell cycle and identified dynamic transcriptional signatures across the cell cycle.

Indexed as

Cell CycleTranscription, GeneticChromatin ImmunoprecipitationHistonesHumansKruppel-Like Factor 4MCF-7 CellsSequence Analysis, RNAHistonesKLF4 protein, humanKruppel-Like Factor 4cell cycleepigeneticsGRO-seqnascent RNAtranscriptional regulation

Identifiers

PMID28289232
PMCPMC5380023
OpenAlexW2597003728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.